Advanced Search

Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2010 November;76(11) > Minerva Anestesiologica 2010 November;76(11):957-60



A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care

Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,036

Frequency: Monthly

ISSN 0375-9393

Online ISSN 1827-1596


Minerva Anestesiologica 2010 November;76(11):957-60


Successful treatment of multidrug-resistant Acineto-bacter baumannii ventriculitis with intrathecal and intravenous colistin

De Pascale G. 1, Pompucci A. 2, Maviglia R. 3, Spanu T. 4, Bello G. 3, Mangiola A. 2, Scoppettuolo G. 1

1 Institute of Infectious Diseases, Catholic University School of Medicine, Rome, Italy;
2 Institute of Neurosurgery, Catholic University School of Medicine, Rome, Italy;
3 Department of Anesthesiology and Intensive Care, Catholic University School of Medicine, Rome, Italy;
4 Institute of Microbiology, Catholic University School of Medicine, Rome, Italy

Acinetobacter baumannii (AB) nosocomial infections, especially those due to multi-drug resistant (MDR) strains, are increasingly detected. We report a case of a 42-year-old male patient affected by low-grade ependymoma who developed AB-MDR post-neurosurgical ventriculitis. Initially, because of in vitro susceptibility, we used a combination of intravenous colistin and tigecycline. This treatment resulted in the improvement of the patient’s initial condition. However, soon after, the infection relapsed; tigecycline was stopped and treatment with intrathecal colistin was initiated. Cure was achieved by continuing this treatment for approximately three weeks, without adverse effects.

language: English


top of page